CDK1 and hepatocellular carcinoma: Similarly, it has been observed that CDK1 is active in hepatocellular carcinoma cells, where its knockdown affects Apoptin localization and activity, thus pointing toward an interaction between the two proteins, and possibly CDK1-driven Apoptin phosphorylation (Zhao et al., 2013).